Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoi ndoline-1,3-dione

Details for Australian Patent Application No. 2010249615 (hide)

Owner Celgene Corporation

Inventors Tutino, Anthony; Kelly, Michael T.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010249615

PCT Pub. Number WO2010/135396

Priority 61/179,678 19.05.09 US

Filing date 19 May 2010

Wipo publication date 25 November 2010

International Classifications

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/454 (2006.01)

Event Publications

8 September 2011 PCT application entered the National Phase

  PCT publication WO2010/135396 Priority application(s): WO2010/135396

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010249619-Magnetometer-based detector for objects in a pipeline

2010249593-Methods for providing personalized medicine tests ex vivo for hematological neoplasms